Gemcitabine Re-Challenge in Metastatic Soft Tissue Sarcomas: A Therapeutic Option for Selected Patients

Anticancer Research - Greece
doi 10.21873/anticanres.13118
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Institute of Anticancer Research

Related search

Therapeutic Efficacy and Dosage of Pazopanib for Metastatic or Unresectable Advanced Soft Tissue Sarcomas

Chemotherapy: Open Access
2014English

Guidelines for the Management of Soft Tissue Sarcomas

Sarcoma
Nuclear MedicineRadiologyImagingOncology
2010English

Notch Signaling in Pediatric Soft Tissue Sarcomas

BMC Medicine
Medicine
2012English

Chemotherapy in Pediatric-Type Soft-Tissue Sarcomas

Current Oncology
Oncology
2020English

Pediatric Bone and Soft-Tissue Sarcomas

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2015English

Risk Stratification of Patients Undergoing Pulmonary Metastasectomy for Soft Tissue and Bone Sarcomas

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2015English

Vascular Reconstruction in the Resection of Soft Tissue Sarcomas

Perspectives in Vascular Surgery
2000English

Gemcitabine and Docetaxel Combination Chemotherapy for Advanced Bone and Soft Tissue Sarcomas: Protocol for an Open-Label, Non-Randomised, Phase 2 Study

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Matrix Metalloproteinase Expression in High Grade Soft Tissue Sarcomas

Oncology Reports
MedicineCancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy